• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Type 2 Diabetes Mellitus Treatment Market

    ID: MRFR/Pharma/4214-HCR
    85 Pages
    Rahul Gotadki
    September 2025

    Type 2 Diabetes Mellitus Treatment Market Research Report Information By Treatment (Drug (Insulin, Sensitizers, Sglt-2, Alpha-Glucosidase Inhibitors, Others), Devices (Blood Glucose Monitoring, Insulin Delivery Devices)), By The End User – Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Type 2 Diabetes Mellitus Treatment Market Summary

    As per Market Research Future Analysis, the Type 2 Diabetes Mellitus Treatment Market was valued at USD 18.53 Billion in 2023 and is projected to grow to USD 39.18 Billion by 2032, with a CAGR of 9.45% from 2024 to 2032. The market is driven by rising technological advancements, increasing prevalence of diabetes, and growing awareness about the condition. Key players are developing novel drugs and devices, such as Ozempic and Steglatro, to address the unmet medical needs. However, challenges such as high treatment costs and side effects may hinder growth. The Americas dominate the market due to high healthcare expenditure and patient population, while Asia Pacific is the fastest-growing region.

    Key Market Trends & Highlights

    The Type 2 Diabetes Mellitus Treatment Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 18.53 Billion
    • Projected Market Size by 2032: USD 39.18 Billion
    • CAGR from 2024 to 2032: 9.45%
    • 9.4% of the U.S. population had diabetes in 2015, equating to 30.3 million people

    Market Size & Forecast

    2023 Market Size USD 18.53 Billion
    2024 Market Size USD 18.86 Billion
    2032 Market Size USD 39.18 Billion

    Major Players

    Abbott Laboratories, Acon Laboratories, Inc., Adocia, Akros Pharma, Amgen, AstraZeneca, Bayer AG, Becton Dickinson and Company, Biocon, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Merck, Novartis & Co., Novo Nordisk, Peptron, Pfizer, Roche Diagnostics Ltd., Sanofi, Sunpharma, Takeda Pharmaceuticals

    Type 2 Diabetes Mellitus Treatment Market Trends

    The increasing prevalence of Type 2 Diabetes Mellitus is driving a paradigm shift towards more personalized treatment approaches, emphasizing the need for innovative therapies and comprehensive management strategies.

    Centers for Disease Control and Prevention (CDC)

    Type 2 Diabetes Mellitus Treatment Market Drivers

    Rising Prevalence of Type 2 Diabetes

    The increasing prevalence of Type 2 Diabetes Mellitus globally is a primary driver for the Global Type 2 Diabetes Mellitus Treatment Market Industry. As lifestyle changes and dietary habits contribute to higher obesity rates, the World Health Organization indicates that the number of adults with diabetes has risen significantly. In 2024, the market is projected to reach 18.9 USD Billion, reflecting the urgent need for effective treatment options. This trend is expected to continue, with estimates suggesting that by 2035, the market could expand to 51.4 USD Billion, highlighting the growing demand for innovative therapies and management solutions.

    Market Segment Insights

    Regional Insights

    Key Companies in the Type 2 Diabetes Mellitus Treatment Market market include

    Industry Developments

    • Q2 2025: ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide At the 85th Scientific Sessions of the American Diabetes Association in June 2025, Eli Lilly's tirzepatide (Mounjaro, Zepbound) was highlighted for its unique mechanism and clinical data supporting its use in type 2 diabetes management. The session provided updated insights into tirzepatide’s FDA-approved indications and its role in personalized treatment plans.

    Type 2 Diabetes Mellitus Treatment Market Regional Analysis

    The Americas dominate the type 2 diabetes mellitus treatment market owing to the presence of patient population, a well-developed technology, high healthcare expenditure, and the presence of the leading players. Due to the rising prevalence of diabetes, various companies, and government associations are actively participating in improving diabetes care. For instance, The Merck Foundation has provided funding of around USD 10,000,000 for the projects designed to improve diabetes care in the United States.

    Europe holds the second position in the type 2 diabetes mellitus treatment market. It is expected that the government support towards research & development expenditure and amendments in reimbursement policies in the healthcare is likely to drive the European market. As per the German maternity guidelines, every pregnant woman can undergo glucose challenge test for the early diagnosis of Gestational diabetes mellitus, and the charges for the test are completely covered by women’s health insurance.

    Asia Pacific is the fastest growing type 2 diabetes mellitus treatment market owing to a huge patient pool, increasing demand, and development in healthcare technology.

    The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

    Type 2 Diabetes Mellitus Treatment Market Key Players

    Some of key the players in the global type 2 diabetes mellitus treatment market are: 

    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Adocia
    • Akros Pharma
    • Amgen
    • AstraZeneca
    • Bayer AG
    • Becton 
    • Dickinson and Company
    • Biocon
    • Boehringer Ingelheim
    • Daiichi Sankyo
    • Eli Lilly
    • Merck
    • Novartis & Co.
    • Novo Nordisk
    • Peptron
    • Pfizer
    • Roche Diagnostics Ltd.
    • Sanofi
    • Sunpharma
    • Takeda Pharmaceuticals

    Intended Audience

    • Pharmaceutical Companies
    • Medical Device Companies
    • Research and Development (R&D) Companies
    • Diagnostic Laboratories
    • Government Research Institute
    • Academic Institutes and Universities

    Future Outlook

    Type 2 Diabetes Mellitus Treatment Market Future Outlook

    The Type 2 Diabetes Mellitus Treatment Market is projected to grow at a 9.54% CAGR from 2024 to 2035, driven by increasing prevalence, technological advancements, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop personalized medicine approaches to enhance treatment efficacy and patient adherence.
    • Invest in digital health solutions for remote monitoring and management of diabetes.
    • Expand access to affordable treatment options in emerging markets to capture new patient demographics.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment and increased global awareness.

    Market Segmentation

    Type 2 Diabetes Mellitus Treatment Market Segmentation

    Intended Audience
    • Pharmaceutical Companies
    • Medical Device Companies
    • Research and Development (R&D) Companies
    • Diagnostic Laboratories
    • Government Research Institute
    • Academic Institutes and Universities

    Report Scope

    Report Attribute/Metric Details  
      Market Size   USD 39.18 Billion by 2032  
      CAGR   9.45%  
      Base Year   2023  
      Forecast Period   2024-2032  
      Historical Data Market Size 2023 18.53 (USD Billion)
      Forecast Units Market Size 2024 18.86 (USD Billion)
      Report Coverage Market Size 2032 39.18 (USD Billion)
      Segments Covered Compound Annual Growth Rate (CAGR) 9.45 % (2024 - 2032)
      Geographies Covered Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Key Vendors Base Year 2023
      Key Market Opportunities Market Forecast Period 2024 - 2032
      Key Market Drivers Historical Data 2019 - 2023

     

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    1. Chapter 1.    Report Prologue  
    2. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective  
        2.     Assumptions    
    3.  Limitations    
    4. Chapter 3.    Research
    5. Methodology
      1.     Introduction
      2.     Primary
    6. Research    
      1.     Secondary research  
      2.     Market Size Estimation
    7. Chapter 4.  
    8.  Market Dynamics
      1.     Drivers    
    9.  Restrains
      1.     Opportunities    
    10.  Challenges
      1.     Macroeconomic Indicators
    11.  Technology Trends & Assessment          
    12. Chapter 5.    Market Factor Analysis
    13.  Porter’s Five Forces Analysis
      1.     Bargaining
    14. Power of Suppliers    
      1.     Bargaining Power
    15. of Buyers
      1.     Threat of New Entrants    
        1.     Threat of Substitutes    
    16.  Intensity of Rivalry    
      1.     Value Chain
    17. Analysis
      1.     Investment Feasibility Analysis  
      2.     Pricing Analysis
    18. Chapter 6.    Global
    19. Type 2 diabetes mellitus treatment Market, by treatment
      1.     Introduction
      2.     Drug Class
        1.     Market Estimates
    20. & Forecast, 2020 – 2027
      1.     Devices
    21.  Market Estimates & Forecast, 2020 – 2027
      1.     Others
        1.     Market Estimates & Forecast, 2020 – 2027
    22. Chapter 7.    Global Type 2 diabetes mellitus treatment Market,
    23. by End User
      1.     Introduction
      2.     Hospitals 
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Clinics
        1.     Market Estimates &
    24. Forecast, 2020 – 2027
      1.     Diagnostic Centers
    25.  Market Estimates & Forecast, 2020 – 2027
      1.     Drug
    26. Stores
      1.     Market Estimates & Forecast, 2020 –
      2.     Pharmacies
        1.     Market Estimates
    27. & Forecast, 2020 – 2027
      1.     Others
    28.  Market Estimates & Forecast, 2020 – 2027
    29. Chapter 8.  
    30.  Global Type 2 diabetes mellitus treatment Market, by Region
    31.  Introduction
      1.     Americas
        1.     North
    32. America
      1.     U.S.
        1.     Canada
        2.     South America
      2.     Europe
    33.  Western Europe
      1.     Germany
    34.  France
      1.     Italy
        1.     Spain
        2.     Eastern Europe
      2.     Asia Pacific
        1.     Japan
        2.     China
    35.  India
      1.     Australia
        1.     Republic
    36. of Korea
      1.     Rest of Asia Pacific
    37.  The Middle East & Africa
      1.     United Arab Emirates
        1.      Saudi Arabia
        2.     Oman
    38.  Kuwait
      1.     Qatar
        1.     Rest
    39. of the Middle East & Africa
    40. Chapter 9    Company Landscape  
      1.     Introduction    
    41.  Market Share Analysis    
      1.     Key Development
    42. & Strategies    
      1.     Key Developments  
    43. Chapter 10    Company Profiles    
      1.     Abbott Laboratories 
        1.     Company
    44. Overview    
      1.     Types Overview  
        1.     Financials    
    45.  SWOT Analysis    
      1.     AstraZeneca  
        1.     Company Overview    
    46.  Types Overview    
      1.     Financial
    47. Overview    
      1.     Key Developments  
        1.     SWOT Analysis    
    48.  Eli Lilly
      1.     Company Overview    
        1.     Types Overview    
    49.  Financial Overview
      1.     Key Development  
        1.     SWOT Analysis    
    50.  Merck
      1.     Company Overview    
        1.     Types/Business Segment Overview    
        2.     Financial Overview    
    51.  Key Development    
      1.     SWOT Analysis  
      2.     BECTON, DICKINSON AND COMPANY
    52.  Company Overview    
      1.     Types Overview  
        1.     Financial overview    
    53.  Key Developments    
      1.     Sanofi  
        1.     Company Overview    
    54.  Types Overview    
      1.     Financial
    55. Overview    
      1.     Key Developments  
      2.     BOEHRINGER INGELHEIM
    56.  Overview    
      1.     Types Overview  
        1.     Financials    
    57.  Key Developments    
      1.     SWOT Analysis  
    58.         10.8    Others
    59. Chapter 11    MRFR Conclusion    
    60.  Key Findings    
      1.     From CEO’s
    61. View Point    
      1.     Unmet Needs of the Market  
      2.     Key Companies to Watch    
      3.     Prediction of Type 2 diabetes mellitus treatment industry
    62. Chapter 12    Appendix
    63.         Type 2 diabetes mellitus treatment Industry
    64. Synopsis, 2020 – 2027
    65. diabetes mellitus treatment Market Estimates and Forecast, 2020 – 2027,
    66. (USD Million)
    67. mellitus treatment Market by Region, 2020 – 2027, (USD Million)
    68.         Type 2 diabetes mellitus treatment Market
    69. by Treatment, 2020 – 2027, (USD Million)
    70.  Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    71. (USD Million)
    72. treatment Market by Treatment, 2020 – 2027, (USD Million)
    73.  North America Type 2 diabetes mellitus treatment Market by End Users, 2020
    74. – 2027, (USD Million)
    75. treatment Market by Treatment, 2020 – 2027, (USD Million)
    76.  US Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    77. (USD Million)
    78. Market by Treatment, 2020 – 2027, (USD Million)
    79.  Canada Type 2 diabetes mellitus treatment market by End Users, 2020 –
    80. , (USD Million)
    81. mellitus treatment Market by Treatment, 2020 – 2027, (USD Million)
    82.     South America Type 2 diabetes mellitus treatment Market by
    83. End Users, 2020 – 2027, (USD Million)
    84. Type 2 diabetes mellitus treatment Market by Treatment, 2020 – 2027, (USD
    85. Million)
    86. Market by End Users, 2020 – 2027, (USD Million)
    87.  Western Europe Type 2 diabetes mellitus treatment Market by Treatment, 2020
    88. – 2027, (USD Million)
    89. diabetes mellitus treatment Market by End Users, 2020 – 2027, (USD Million)
    90. by Treatment, 2020 – 2027, (USD Million)
    91. Europe Type 2 diabetes mellitus treatment Market by End Users, 2020 – 2027,
    92. (USD Million)
    93. treatment Market by Treatment, 2020 – 2027, (USD Million)
    94.  Asia Pacific Type 2 diabetes mellitus treatment market by End Users, 2020
    95. – 2027, (USD Million)
    96. Africa Type 2 diabetes mellitus treatment Market by Treatment, 2020 – 2027,
    97. (USD Million)
    98. diabetes mellitus treatment market by End Users, 2020 – 2027, (USD Million)
    99. Market
    100. mellitus treatment Market
    101. mellitus treatment market Share, by Treatment 2020
    102. Type 2 diabetes mellitus treatment market Share, by End Users, 2020
    103.     Global Type 2 diabetes mellitus treatment market Share, by Region,
    104. market Share, by Country, 2020
    105. mellitus treatment market Share, by Country, 2020
    106. Pacific Type 2 diabetes mellitus treatment market Share, by Country, 2020
    107.     Middle East & Africa Type 2 diabetes mellitus treatment
    108. market Share, by Country, 2020
    109. mellitus treatment market: Company Share Analysis, 2020 (%)
    110.  Abbott Laboratories: Key Financials
    111. Laboratories: Segmental Revenue
    112. Geographical Revenue
    113.  AstraZeneca: Geographical Revenue
    114. Key Financials
    115.  Merck: Key Financials
    116.  BECTON, DICKINSON AND COMPANY: Key Financials
    117. DICKINSON AND COMPANY: Segmental Revenue
    118. DICKINSON AND COMPANY Geographical Revenue
    119. Key Financials
    120.     Sanofi: Geographical Revenue
    121. INGELHEIM: Key Financials
    122. Segmental Revenue
    123. Revenue

    Type 2 Diabetes Mellitus Treatment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027